| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cytoplasmic ribosomal proteins 0.5963420234724652 3.877046144779664 0.0001057323109359 0.0617698093731341 0.0637565834943562 72 P62280,P46779,P62424,P46776,P46777,P62829,P61513,P49207,P39023,P42766,P61254,P40429,P18077,P61247,P62266,P62753,P46778,P27635,P62917,P35268,Q02543,P84098,P62263,Q9Y3U8,P61313,P47914,P62851,P60866,P39019,P62910,P61353,Q02878 32 |
| Mitochondrial complex iv assembly 0.7010981536441375 2.183584052519413 0.0289928264602108 0.9999999802698524 1.0 10 P09669,O43819,P20674,Q9Y241,P13073 5 |
| Mitochondrial long chain fatty acid betaoxidation 0.6509910103153539 2.0603006319505694 0.0393698095578995 0.9999999999697023 1.0 14 P40939,O43772,P11310 3 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.645364796186802 2.028691699256096 0.0424897018953669 0.9999999999957392 1.0 12 P13674,Q96AY3,P23284,O15460,P07237,Q5JRA6 6 |
| Aerobic glycolysis 0.6608692383394406 1.973807940788766 0.0484035855826876 0.9999999999998984 1.0 10 P04406,P06744,P08237,P00338,P04075 5 |
| Ketogenesis and ketolysis 0.7774685663971368 1.86406334901377 0.0623128087002893 1.0 1.0 5 O43772 1 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.6627911896096285 1.8556334525549056 0.0635058221071143 1.0 1.0 9 P56545,Q86UE4,P49841,P67870 4 |
| Il5 signaling pathway 0.6037034422227578 1.7947572175791948 0.0726923898794875 1.0 1.0 12 P49840,P28482,P62753,P49841 4 |
| Aryl hydrocarbon receptor pathway wp2873 0.7921298119040504 1.7346917199825782 0.082795423679737 1.0 1.0 4 Q15185,P07900 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7032233373146217 1.7304644479519873 0.0835473278504856 1.0 1.0 6 P07099 1 |
| Neural crest differentiation 0.6373514054248315 1.7251883484184858 0.0844935347907267 1.0 1.0 9 P49841,Q04721,Q9NR77,P56545,P35222 5 |
| Mitochondrial complex iii assembly 0.6366694940510119 1.7216706628271805 0.0851291946339838 1.0 1.0 9 Q6DKK2,Q9UDW1 2 |
| Il2 signaling pathway 0.6116705528918513 1.7110005970480473 0.0870810026107402 1.0 1.0 10 P62753,P28482 2 |
| Sudden infant death syndrome sids susceptibility pathways 0.5615714323969604 1.6942244779006947 0.090222635156377 1.0 1.0 27 P04406,P11310,Q04917,P61981,Q9H0U9,P42892,P40939,P62258,P14625,P27348,P04075 11 |
| Translation factors 0.5102712970277928 1.6835472158222362 0.0922692071296276 1.0 1.0 36 Q13347,P24534,Q13144,O75822,O15372,O75821,P55884,Q9UI10,Q9H074,Q15056,Q9NR50,O75153,P20042,P63241,P26641 15 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.5753129404517203 1.6277963445508972 0.1035680759009345 1.0 1.0 13 Q13347,O75822,O15372,O75821,P20042 5 |
| Hijack of ubiquitination by sarscov2 0.6788425108660792 1.6190614253553444 0.1054340474727415 1.0 1.0 6 Q9C0D3,Q15369,Q13564 3 |
| Sleep regulation 0.7595544483189172 1.598067794171177 0.1100278901641034 1.0 1.0 4 P00813 1 |
| Mirna regulation of prostate cancer signaling pathways 0.6333564545919963 1.5946058810996162 0.1108003966440638 1.0 1.0 8 P28482,Q02750,P35222,P49841 4 |
| Il7 signaling pathway 0.6640225026698393 1.5508948963511602 0.1209268736975595 1.0 1.0 6 P49841,P28482 2 |
| Cori cycle 0.5578959775605491 1.538886320646191 0.1238320512841668 1.0 1.0 11 P04406,P06744,P37837,P04075,P18669 5 |
| Fatty acid betaoxidation 0.5558876439972681 1.5297968237105557 0.1260670280738876 1.0 1.0 20 O43772,P40939,P11310 3 |
| Krebs cycle disorders 0.6577588824779803 1.521992589253155 0.1280109375832721 1.0 1.0 6 Q96I99,P53597,Q9P2R7,O00330,P36957 5 |
| Striated muscle contraction pathway 0.7393019726858895 1.5125677979961627 0.1303894790220994 1.0 1.0 4 P67936,O43707,P06753 3 |
| Type 2 papillary renal cell carcinoma 0.626296337804719 1.4624258531801186 0.143624549142924 1.0 1.0 7 P23246,Q15369,Q92733 3 |
| Acetylcholine synthesis 0.8305832761358427 1.4488657650614027 0.147375073429002 1.0 1.0 3 P49585 1 |
| Photodynamic therapyinduced hif1 survival signaling 0.6017924007856748 1.4363230890892678 0.1509104269507797 1.0 1.0 8 P08559,P00338,P53985 3 |
| Exerciseinduced circadian regulation 0.5402555545984252 1.4181606469032058 0.1561438683416662 1.0 1.0 14 Q9P0L0,P31689,Q96KR1,Q9Y2A7 4 |
| Intraflagellar transport proteins binding to dynein 0.5739900470913306 1.3942697873832568 0.1632361507805866 1.0 1.0 9 Q9Y6G9,P63167 2 |
| Nanoparticlemediated activation of receptor signaling 0.6297188588413722 1.3920377708936342 0.1639109605498203 1.0 1.0 6 Q02750,P28482 2 |
| Prolactin signaling pathway 0.5343101399936495 1.387166335560604 0.1653910481243228 1.0 1.0 19 P63000,P62753,P05556,P61981,P49841,P23284,P21333,P28482,P63104,Q02750 10 |
| Tca cycle aka krebs or citric acid cycle 0.5346754473986004 1.380959194753642 0.167291507475404 1.0 1.0 16 P31040,P53597,O75390,O43837,P48735,P50213,P51553 7 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.6256108330599582 1.3729330834518818 0.1697731505146864 1.0 1.0 6 P35222,P27348 2 |
| T cell receptor and costimulatory signaling 0.6064881855146704 1.3666498485965686 0.1717350844939971 1.0 1.0 7 P49840,Q08209 2 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.6612250010565048 1.3539898559252512 0.1757396140699765 1.0 1.0 5 P55263,Q9NZL9 2 |
| Endothelin pathways 0.5571219595351721 1.3050757573977494 0.1918670527327717 1.0 1.0 9 P42892,Q02750,Q05682,P28482 4 |
| Leukocyteintrinsic hippo pathway functions 0.6851582998278333 1.282657093127772 0.1996122383389125 1.0 1.0 4 P27348 1 |
| Transsulfuration and onecarbon metabolism 0.5121901693197773 1.2487268978448145 0.211764979337365 1.0 1.0 19 O43865,O43175,P48507,Q9NZL9,P23526,Q9Y617,P13995 7 |
| Fbxl10 enhancement of maperk signaling in diffuse large bcell lymphoma 0.581276096240318 1.244263604697264 0.2134025613457466 1.0 1.0 7 P16104,Q9P0M6,P84243,P28482 4 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.5959366422693408 1.2346208902811435 0.2169716305324005 1.0 1.0 6 P28482 1 |
| Wntbetacatenin signaling pathway in leukemia 0.6717864065072247 1.225768907496723 0.2202856508711672 1.0 1.0 4 P49841 1 |
| Influence of laminopathies on wnt signaling 0.5226187643702135 1.2212472698303505 0.2219924116504894 1.0 1.0 10 O75844,P50402,O60725,P49841 4 |
| Hepatocyte growth factor receptor signaling 0.5396935818228469 1.2126512610287337 0.2252631814618741 1.0 1.0 9 Q02750,P05556,P28482 3 |
| Amino acid metabolism 0.3350542682122788 1.1894682859470558 0.2342554435888746 1.0 1.0 56 P14618,P19623,P48507,P31040,P53597,P48637,P40925,P07814,P11310,O75390,P00338,P26640,P25325,Q05682,O15460,P40939,P00505,P08243,P36957,P08559,P27708,P11766 22 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.6598910606466193 1.1751997113010997 0.2399148257218639 1.0 1.0 4 P21333,P28482 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.7497295002213231 1.1338988065281743 0.2568369978105367 1.0 1.0 3 P49841 1 |
| Epo receptor signaling 0.5549437469982912 1.1162527447157076 0.2643139629301068 1.0 1.0 7 P28482 1 |
| Constitutive androstane receptor pathway 0.6053842287621876 1.105526465404143 0.268931533208478 1.0 1.0 5 P07900,P08183 2 |
| Parkinsons disease pathway 0.519219655343618 1.1039548937051025 0.2696127047461574 1.0 1.0 9 Q9Y385,Q99497,P68036,Q99700,P07814 5 |
| Vegfavegfr2 signaling pathway 0.436526201109599 1.0995812357459338 0.2715146213263599 1.0 1.0 170 Q01968,P62280,O14964,P24666,P51571,P54646,P00367,P49257,P49327,P20338,O75569,P63244,Q7Z478,Q99832,Q9UG63,P09429,Q08209,P30041,Q5VU43,Q02750,P11171,Q12849,P35222,P46777,P04075,P78344,P07814,P04406,P06730,Q00059,P18124,P11940,P06753,O43852,P61254,O14773,P48735,Q4VCS5,Q9Y520,P31689,P40429,O15355,O14908,P07900,P42566,O60885,Q14157,P18206,P00338,P62753,P19174,Q15369,Q16527,Q15293,O15460,P62258,Q15075,Q02543,P07237,P35613,P52209,P27797,P05556,P28482,P49841,O75116,Q01105,O15372,O00299,P17655,P61421,Q9HCE1,Q9H2U1,P61353,P29401,Q6Y7W6 76 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.4876613484669159 1.0986154234289978 0.2719358473710476 1.0 1.0 15 P49841,P50402,O75844,O60725,P35222 5 |
| Glycogen synthesis and degradation 0.4800571950725324 1.048671273815866 0.2943294397622509 1.0 1.0 16 P49841,P36871,P13807,P30153,Q14738,Q16851,P49840,P35573,P52789 9 |
| Interactome of polycomb repressive complex 2 prc2 0.5557625701167517 1.0473337740187203 0.29494566425703 1.0 1.0 6 Q9NYF8,Q9Y2W1 2 |
| Endometrial cancer 0.4682573456762307 1.0168030801786936 0.3092471165510302 1.0 1.0 11 P28482,Q02750,P35222,P49841 4 |
| Angiotensin ii receptor type 1 pathway 0.718932869356042 1.0150170706543844 0.3100976902868761 1.0 1.0 3 P28482 1 |
| Angiogenesis 0.7178215524165558 1.0107517866110003 0.3121352441701062 1.0 1.0 3 P28482 1 |
| Glucocorticoid receptor pathway 0.5445333863752057 0.9952127514882306 0.3196328012475682 1.0 1.0 6 P07900 1 |
| Serotonin receptor 467 and nr3c signaling 0.7114436669262045 0.9863139832136892 0.3239790600632375 1.0 1.0 3 P28482 1 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.7114436669262045 0.9863139832136892 0.3239790600632375 1.0 1.0 3 P28482 1 |
| Pi3kaktmtor vitd3 signaling 0.576279030058162 0.9767709720380352 0.3286825499552424 1.0 1.0 5 P08559,P54646,P49841 3 |
| Mitochondrial gene expression 0.5341589222729679 0.9472349024301944 0.3435190939511408 1.0 1.0 6 Q00059,Q08209 2 |
| Effect of progerin on genes involved in hutchinsongilford progeria syndrome 0.4610610172411734 0.9451101196229178 0.3446026594660343 1.0 1.0 14 P83916,P84243 2 |
| Map3k1 role in promoting and blocking gonadal determination 0.5658682562329852 0.9310476247151672 0.3518289294229315 1.0 1.0 5 P49841,P28482 2 |
| Il9 signaling pathway 0.5161690243742386 0.9286550027594368 0.3530679072410847 1.0 1.0 7 P28482 1 |
| Photodynamic therapyinduced unfolded protein response 0.4852175862342995 0.924080545399925 0.3554443814845587 1.0 1.0 9 P14625,P27797 2 |
| Mapk cascade 0.5286676521556462 0.921925779883424 0.3565672910108093 1.0 1.0 6 P28482 1 |
| Metabolism of spingolipids in er and golgi apparatus 0.5605611074379173 0.9078309455865154 0.3639675459963403 1.0 1.0 5 Q10472 1 |
| Pdgf pathway 0.4514703300255732 0.907126971983253 0.3643396563550523 1.0 1.0 12 P63000,P28482,P19174,P53365,Q02750 5 |
| Omega9 fatty acid synthesis 0.5226931286467363 0.8944688295325539 0.3710711000672275 1.0 1.0 6 O60488 1 |
| Methionine de novo and salvage pathway 0.49460146797859 0.8941076164751038 0.3712643145544225 1.0 1.0 8 Q9NZL9,Q13126,Q9BV57 3 |
| Tca cycle and deficiency of pyruvate dehydrogenase complex pdhc 0.4535807101785369 0.8936174380794111 0.3715266129930401 1.0 1.0 15 P31040,P08559,O75390,P50213,P40925 5 |
| Metabolic reprogramming in colon cancer 0.4107167406174201 0.882748369831037 0.3773722417001941 1.0 1.0 36 P04406,P06744,P14618,Q06203,P00338,P00367,P08559,P37837,P48735,P50213,P36957,Q9Y617,P00505,P29401,P52209,P18669 16 |
| Serine metabolism 0.5191950456068185 0.8784354343236875 0.379707461895604 1.0 1.0 6 Q9Y617 1 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.6826456310679725 0.8770079073184223 0.3804823431685125 1.0 1.0 3 P19174,P28482 2 |
| Transsulfuration pathway 0.4904368155361688 0.8732729967509973 0.3825142953154667 1.0 1.0 8 P23526,P48507,Q9NZL9 3 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.5872534142640337 0.869769583402568 0.3844263369323046 1.0 1.0 4 P06730,P06753,P61201 3 |
| Ccl18 signaling pathway 0.4715598862387961 0.8524531218282374 0.3939626469695945 1.0 1.0 9 Q86UE4,P00338,P27144,P33176 4 |
| Proteasome degradation 0.3832929309023762 0.8369134715184284 0.4026412074427326 1.0 1.0 40 P49721,O43242,P51665,P22314,P25786,P25788,P62191,P28070,P04843,P43686,P62333,P16104,Q99460,Q13200,P13747,P28074 16 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4649865706274642 0.8181859835993489 0.4132509973677949 1.0 1.0 9 P06730,P05556,P49841,P49770,P08069,Q13418 6 |
| Vasopressinregulated water reabsorption 0.440942856542884 0.8079028344039144 0.4191465195081143 1.0 1.0 17 Q9Y6G9,Q12846,P63167 3 |
| Sphingolipid pathway 0.432083603906804 0.8068166077080575 0.4197721494150168 1.0 1.0 11 Q96G23,Q9Y5P4 2 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.5711914693622893 0.8038057734840417 0.421509154906877 1.0 1.0 4 P08670,P28482 2 |
| Oxidation by cytochrome p450 0.5003541491579214 0.7927293348985524 0.4279355352762886 1.0 1.0 6 O43169 1 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.4446037458677843 0.7893978938780191 0.4298794864757878 1.0 1.0 10 P63000,P28482,Q02750,P49840,O14646 5 |
| Preimplantation embryo 0.4863267766203968 0.786461935580222 0.4315969107317587 1.0 1.0 7 Q92945 1 |
| Nuclear receptors metapathway 0.3127259114236794 0.7790708189858789 0.4359379986278053 1.0 1.0 49 P48507,Q15185,P08183,Q99735,P11310,P06493,P30043,Q9HCL2,Q99615,P30041,O00170,O00767,P07900,P08238,P52209 15 |
| Glycolysis and gluconeogenesis 0.4298118264574679 0.774131489968879 0.4388530372313646 1.0 1.0 26 P04406,P06744,P07195,P08237,P00338,P08559,P00505,P40925,P04075,P18669 10 |
| Pparalpha pathway 0.4836302465202076 0.7737666294643379 0.4390688098523938 1.0 1.0 7 P11310 1 |
| Hair follicle development organogenesis part 2 of 3 0.6544296116504862 0.772093539752569 0.4400590281935124 1.0 1.0 3 P35222,P05556 2 |
| Interleukin11 signaling pathway 0.4272505571864839 0.7553663937715283 0.4500291715799347 1.0 1.0 13 O75925,P62753,P28482 3 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.4267284691980245 0.7523456105502242 0.4518432456617463 1.0 1.0 13 P40925,O43819,P17096 3 |
| Pregnane x receptor pathway 0.5194628284316278 0.7310026420834799 0.4647775391318971 1.0 1.0 5 P07900,P08183 2 |
| Il3 signaling pathway 0.4229323688869143 0.7304271176904151 0.4651291475599892 1.0 1.0 13 P27348,P28482 2 |
| Serotonin htr1 group and fos pathway 0.4612380117948356 0.7289176440687225 0.4660520411911832 1.0 1.0 8 P09471,P28482 2 |
| Orexin receptor pathway 0.4272431761509651 0.7203747476481953 0.4712942936173956 1.0 1.0 19 P20290,P55145,Q00059,P28482 4 |
| Physiological and pathological hypertrophy of the heart 0.4705416524280836 0.7126143879524749 0.4760844060286926 1.0 1.0 7 Q08209 1 |
| Interferon type i signaling pathways 0.4197490875966485 0.6937759131287613 0.4878227503324872 1.0 1.0 15 P06730,P62753,P63244,P60842,O75925 5 |
| Purine metabolism 0.439280793575783 0.685982246372763 0.4927243038447413 1.0 1.0 9 P00813,P30566,P31939 3 |
| Corticotropinreleasing hormone signaling pathway 0.4212883835064792 0.6843941850790495 0.4937262869146885 1.0 1.0 19 P49841,P54646,P28482,P07900,P42892,Q02750,P09471 7 |
| Regulatory circuits of the stat3 signaling pathway 0.4636883164776516 0.6809444479750151 0.4959066419224296 1.0 1.0 7 P28482 1 |
| Hif1a and pparg regulation of glycolysis 0.6289333954379488 0.6798328048552837 0.4966103325189901 1.0 1.0 3 P04406 1 |
| Pentose phosphate metabolism 0.5066993203212639 0.6775245664945853 0.4980731886335157 1.0 1.0 5 P37837,P29401,P52209 3 |
| Aryl hydrocarbon receptor pathway wp2586 0.4361581739372361 0.6701667378779391 0.5027515050198346 1.0 1.0 9 P07900,O00170,P28482 3 |
| Metapathway biotransformation phase i and ii 0.416764007402674 0.6563405016883925 0.51160506348256 1.0 1.0 20 Q8NCH0,Q99735,P07099,P34913,P48637,Q9H0A0,Q86UY6 7 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.4667799478617808 0.6437544503638708 0.5197346749994116 1.0 1.0 6 P18206,P19174,P28482 3 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.4666838650571474 0.6433370050733805 0.5200054495576452 1.0 1.0 6 P06730,Q02750,P28482 3 |
| Ras and bradykinin pathways in covid19 0.6176135447404536 0.6398313378456972 0.5222822567069956 1.0 1.0 3 P28482 1 |
| Purine metabolism and related disorders 0.4064272609122354 0.6259031085684311 0.531378495462522 1.0 1.0 14 P00813,Q06203,P31939 3 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.3997314766198422 0.6236422964846625 0.5328625266056308 1.0 1.0 11 Q8TB36,Q9NR77 2 |
| Clear cell renal cell carcinoma pathways 0.3888065152519823 0.6204686317920856 0.5349492996282628 1.0 1.0 33 P04406,O43175,P14618,P06744,P07195,P34896,P00338,P49327,P08237,P36871,Q96G03,Q9Y617,P40925,P04075 14 |
| Embryonic stem cell pluripotency pathways 0.3990269294279626 0.6197322072402764 0.535434107735481 1.0 1.0 11 P28482,Q02750,P49841 3 |
| Phosphoinositides metabolism 0.4363820825341375 0.6094405659604452 0.5422324563189074 1.0 1.0 8 Q01968,O00443,P19174 3 |
| Pathogenic escherichia coli infection 0.4088406115021803 0.6089551283177723 0.5425541817466111 1.0 1.0 21 O75116,Q14247,O15144,P63104,Q92747,P27348 6 |
| Rac1pak1p38mmp2 pathway 0.4028666600027601 0.6057493386307089 0.5446812156201473 1.0 1.0 14 P63000,P05556,P28482,P16949,P35222 5 |
| Dna repair pathways full network 0.2859189064362866 0.6052936772662484 0.5449838817769681 1.0 1.0 56 P18887,P54727,Q9NRF9,P15927,P09429,P39748 6 |
| Cell cycle 0.2872570046555942 0.5884787144611049 0.5562110169503147 1.0 1.0 50 P61981,Q04917,P49841,P06493,O43913,O43684,O43683,Q9UM13,P62258,P27348 10 |
| Oncostatin m signaling pathway 0.3965961605387658 0.5810971775662118 0.5611749607754122 1.0 1.0 13 P62753,P28482 2 |
| Prion disease pathway 0.4415238347237346 0.5805487633515795 0.5615446127098269 1.0 1.0 7 P14625,Q9UQE7,P28482 3 |
| 16p112 distal deletion syndrome 0.4181818648697792 0.580453302445268 0.5616089690031878 1.0 1.0 9 P20338,Q8WWM7 2 |
| Osx and mirnas in tooth development 0.7979981801637841 0.5755953540884 0.5648887220551664 1.0 1.0 2 Q04721 1 |
| Bladder cancer 0.4498041347306146 0.570981527592516 0.5680121646487193 1.0 1.0 6 P28482 1 |
| Thiamine metabolic pathways 0.4786682365957435 0.5634694470026509 0.5731152592784392 1.0 1.0 5 P08559 1 |
| Mevalonate pathway 0.4777051508707823 0.5596478555487491 0.5757196561421343 1.0 1.0 5 Q9BWD1,P14324 2 |
| Base excision repair 0.4000065667031314 0.5560432518260054 0.5781812875003822 1.0 1.0 21 P39748,P09429,P18887 3 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.3915694531908827 0.5532692444648588 0.5800790577118269 1.0 1.0 13 Q8NC51 1 |
| Sarscov2 b117 variant antagonises innate immune activation 0.7888989990900794 0.5484864111160851 0.5833579574307355 1.0 1.0 2 O94826 1 |
| Sphingolipid metabolism overview 0.3973382936202612 0.5388700306260159 0.5899765376243913 1.0 1.0 10 Q96G23,Q9NRA0,O15121 3 |
| Sphingolipid metabolism integrated pathway 0.3973382936202612 0.5388700306260159 0.5899765376243913 1.0 1.0 10 Q96G23,Q9NRA0,O15121 3 |
| 3q29 copy number variation syndrome 0.3886163274259008 0.5263128312611463 0.5986708692878433 1.0 1.0 14 P49585,Q96FJ2,P63167 3 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.4973162539929486 0.5161611335679961 0.6057418732711302 1.0 1.0 4 O60725,P02545 2 |
| Heart development 0.4973123642320365 0.5161469300928369 0.6057517926253388 1.0 1.0 4 P28482 1 |
| Circadian rhythm genes 0.3089834744003644 0.5098000681949708 0.6101915379105773 1.0 1.0 46 Q15233,Q03164,P54646,P49841,P23526,O14744,Q9Y2W1,O75116,Q05086,P23246,Q9BWF3,P00813 12 |
| Osteopontin signaling 0.4939623674236832 0.503961096675757 0.6142887153243111 1.0 1.0 4 P28482 1 |
| Melatonin metabolism and effects 0.493530669072462 0.5023976259545977 0.61538784867661 1.0 1.0 4 P49841 1 |
| Onecarbon metabolism 0.3839704623234981 0.5008929764563353 0.6164464457885059 1.0 1.0 14 P13995,Q9NZL9,P31939 3 |
| Thyroid hormones production and peripheral downstream signaling effects 0.3860080715319219 0.4943959293481452 0.6210265882647377 1.0 1.0 16 P28482,Q02750,P62753,P49841 4 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3848242642336561 0.4810168908029999 0.6305044940808213 1.0 1.0 17 P50402,Q02750,O94901,P28482 4 |
| Arachidonate epoxygenase epoxide hydrolase 0.7649378222626706 0.4794638495650931 0.6316086799141494 1.0 1.0 2 P20674 1 |
| Myometrial relaxation and contraction pathways 0.3862530050072198 0.4794228443476969 0.6316378450785762 1.0 1.0 19 P61981,Q04917,P19174,Q05682,P63104,P62258,Q9UBI6,P27348,P10644,P31946 10 |
| Hedgehog signaling pathway wp47 0.7625113739763454 0.4726787224143201 0.6364424091210859 1.0 1.0 2 O00422 1 |
| G1 to s cell cycle control 0.3823654980711219 0.4694185445930644 0.6387704955045548 1.0 1.0 26 P06493,P15927,P35244 3 |
| Photodynamic therapyinduced ap1 survival signaling 0.4243474322622489 0.4662395199068224 0.64104406432386 1.0 1.0 6 P07900 1 |
| Physicochemical features and toxicityassociated pathways 0.3752536169548558 0.453927888647072 0.6498807298938256 1.0 1.0 14 P07197,P28482,P49841,O75116,Q02750,P35222 6 |
| Alzheimers disease 0.295986715324351 0.45382715845533 0.6499532346249997 1.0 1.0 79 P14735,P25786,P28070,O95197,Q08209,Q02750,P35222,P04406,P67870,Q13564,P33176,Q16186,O43242,P51665,Q07866,P25788,P62191,P28074,P49721,P28482,P49841,P30405,P17655,P43686,Q13200 25 |
| Tumor suppressor activity of smarcb1 0.3680962358142108 0.439423383321622 0.6603547863067938 1.0 1.0 12 Q96GM5 1 |
| Amyotrophic lateral sclerosis als 0.3881338359823777 0.4370540621677322 0.6620721413651198 1.0 1.0 9 Q08209 1 |
| Allograft rejection 0.3745510950891793 0.4253017912709421 0.6706166879226829 1.0 1.0 10 P08183,P49327,Q9BY49,P13747,P08670 5 |
| Chromosomal and microsatellite instability in colorectal cancer 0.372475143002733 0.4209491946869782 0.6737921812240004 1.0 1.0 16 P63000,P28482,P49841,P20585,Q02750,P27361,Q96KP1,P35222 8 |
| Cellular proteostasis 0.4671645271274361 0.4101443823289225 0.681700037098564 1.0 1.0 4 O15212,Q9UHV9 2 |
| Nucleotide excision repair in xeroderma pigmentosum 0.3444734266489723 0.4081770539352805 0.683143693038661 1.0 1.0 37 P18887,P54727,Q9NRF9,P15927,P84243 5 |
| Kisspeptinkisspeptin receptor system in the ovary 0.4083471832975404 0.4037309143395175 0.6864106039203357 1.0 1.0 6 P28482 1 |
| Wnt signaling 0.3642650550224257 0.386395207917507 0.6992039986141023 1.0 1.0 15 P56545,O75116,Q08209,P67870 4 |
| Liver x receptor pathway 0.726417955717328 0.3767035491952882 0.7063939249714855 1.0 1.0 2 O00767 1 |
| Pentose phosphate pathway in senescent cells 0.4258527537516399 0.3664555020487837 0.7140252109143665 1.0 1.0 5 P37837,P29401 2 |
| Cysteine and methionine catabolism 0.3896466695563177 0.3628320407306342 0.7167303555139157 1.0 1.0 7 P23526,P25325,P48637 3 |
| Follicle stimulating hormone fsh signaling pathway 0.3711011025531383 0.3605937783883423 0.7184031409724914 1.0 1.0 9 P28482 1 |
| Hypertrophy model 0.7185319987867874 0.3570629801564375 0.7210446576871394 1.0 1.0 2 O75083 1 |
| Ebsteinbarr virus lmp1 signaling 0.4228077096916752 0.3560147360669331 0.721829529474558 1.0 1.0 5 P07900,P28482 2 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.349726733967427 0.3462487542663676 0.7291557774630162 1.0 1.0 12 P28482,Q05086,P49841 3 |
| Micrornas in cardiomyocyte hypertrophy 0.3619086071119477 0.3428599699477695 0.7317038077403857 1.0 1.0 20 Q13144,P49841,P28482,O75116,Q08209,Q02750,P08069 7 |
| Onecarbon metabolism and related pathways 0.3534791310831015 0.3415177146988011 0.7327138712402792 1.0 1.0 14 O43865,P48507,P34896,P48506,P48637,P49585 6 |
| Proximal tubule transport 0.3566508990281682 0.3409882324054676 0.7331124406119982 1.0 1.0 10 P04920,P08183,P38606 3 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.4443095599393175 0.3360444424478752 0.7368373529765955 1.0 1.0 4 P27361,P35222,P42224 3 |
| Tgfbeta receptor signaling 0.4443095599393175 0.3360444424478752 0.7368373529765955 1.0 1.0 4 P27361,P35222,P42224 3 |
| Energy metabolism 0.352151234933156 0.3349223444622687 0.7376836661400046 1.0 1.0 14 Q00059,Q08209,P49841 3 |
| Spinal cord injury 0.3589742520774128 0.3314076564376238 0.7403365823642254 1.0 1.0 19 O75116,Q08209,P28482 3 |
| Estrogen signaling pathway 0.3876763498685723 0.3275993074421863 0.7432146456480389 1.0 1.0 6 P28482 1 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.3470130118329971 0.3207797149078955 0.7483773328422918 1.0 1.0 13 P56545,P49841,P67870 3 |
| Ptf1a related regulatory pathway 0.6927509857446195 0.2965099703072897 0.7668406539271704 1.0 1.0 2 P35222 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.426013449316856 0.2813014049719664 0.778479232791371 1.0 1.0 4 P49840 1 |
| Mapk pathway in congenital thyroid cancer 0.6824385805277595 0.2739371070887216 0.784132954568941 1.0 1.0 2 Q02750 1 |
| Alzheimers disease and mirna effects 0.2802693387632591 0.273726904219148 0.7842945005431177 1.0 1.0 81 P14735,P25786,P28070,O95197,Q08209,Q02750,P35222,P04406,P67870,Q13564,P33176,Q16186,O43242,P51665,Q07866,P25788,P62191,Q96IX5,P28074,P49721,P28482,P49841,P30405,P17655,P43686,Q13200 26 |
| Alanine and aspartate metabolism 0.4224086595997589 0.2710388095290797 0.786361183337853 1.0 1.0 4 P14868 1 |
| Deregulation of rab and rab effector genes in bladder cancer 0.6809220503488014 0.2707000219244759 0.7866217599458776 1.0 1.0 2 Q8WXG6 1 |
| Androgen receptor signaling pathway 0.3377773784819844 0.2633857609654141 0.7922532643736897 1.0 1.0 32 Q99497,Q02790,Q9UNE7,P62826,Q9UER7,P49841,O75116,Q05086,O75928,P35222,O75925,P27797 12 |
| Urea cycle and metabolism of amino groups 0.3555257920966028 0.2627043166049914 0.792778489450326 1.0 1.0 8 P19623,P12277 2 |
| Malignant pleural mesothelioma 0.2555065702680124 0.2589457000890519 0.7956771368030386 1.0 1.0 58 P56545,P62753,P54646,P67870,P49841,P28482,Q9Y4R8,O14578,Q4VCS5,P09429,Q02750,P08069,P35222 13 |
| Il6 signaling pathway 0.326891091539217 0.2518073776889397 0.8011899544665171 1.0 1.0 11 P28482,P49841 2 |
| Synaptic vesicle pathway 0.333953675284561 0.2480708774649354 0.8040795678694381 1.0 1.0 14 P09496 1 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3286371086330748 0.2467673695928262 0.8050882649341777 1.0 1.0 12 P62753,P28482 2 |
| Retinoblastoma gene in cancer 0.2636815793120848 0.2174420912617685 0.827863831712605 1.0 1.0 48 P06493,P15927,P09429,Q16576,P35244 5 |
| Cannabinoid receptor signaling 0.3488610071870316 0.2169076212325411 0.8282803381149537 1.0 1.0 7 P27361,P10644,P28482 3 |
| Gpr40 pathway 0.6469517743403104 0.2039270602931612 0.8384104983393366 1.0 1.0 2 P19174 1 |
| Glutathione metabolism 0.3494996106269397 0.2036962853460529 0.8385908452048041 1.0 1.0 6 P48507,P48637,P48506 3 |
| Glucuronidation 0.349226910578005 0.202899682542706 0.8392134424147799 1.0 1.0 6 Q96G03,P36871 2 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.4650053893392912 0.1980875417582629 0.842976571939638 1.0 1.0 3 P48637 1 |
| Nonalcoholic fatty liver disease 0.2612888495450304 0.1974130689071801 0.8435043033500711 1.0 1.0 48 O75380,P49840,O75251,P15954,O95168,P31040,P54646,P20674,O95182,P49841,P09669,O96000,P22695,Q9UDW1,P13073 15 |
| Thermogenesis 0.3307551465903495 0.1894806313138269 0.849716134098323 1.0 1.0 28 O43772,O60488 2 |
| Osteoblast differentiation and related diseases 0.3201708134864575 0.1869802054414684 0.8516761530005481 1.0 1.0 10 Q04721,P35222,O00443,P28482 4 |
| Dna mismatch repair 0.3291236176048828 0.1749817308887354 0.8610939887448117 1.0 1.0 22 P15927,Q9NRF9 2 |
| Glycolysis in senescence 0.3158375120737006 0.1705843952881161 0.8645505688261528 1.0 1.0 10 P04406,P00338 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.3268217970707703 0.1625491781299846 0.8708734046253848 1.0 1.0 23 O00767,P14324,O75845,O60488 4 |
| Il4 signaling pathway 0.313631802396272 0.1624111121638756 0.870982120772871 1.0 1.0 10 P28482 1 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.3330889412766002 0.1582032797967245 0.8742966193982415 1.0 1.0 6 Q16527 1 |
| Glial cell differentiation 0.6148013345465602 0.1511835020639108 0.8798309641486859 1.0 1.0 2 P26038 1 |
| Microtubule cytoskeleton regulation 0.3217845464968895 0.1496004739840117 0.8810798342073323 1.0 1.0 20 Q7L7X3,P49841,P06493,Q7KZI7,P16949 5 |
| Ciliary landscape 0.2959121235498783 0.1477025817242933 0.8825774940659428 1.0 1.0 112 O15173,Q8IYI6,P63167,Q15555,Q9Y266,P35222,P84243,P30084,Q9C0D3,P09669,P56545,Q9Y4W6,P07197,Q96FJ2,P51665,P14649,O95292,Q9UN37,Q9UPT5,Q15024,Q96PK6,Q92905,Q7L5N1,P43034,Q9Y6G9 25 |
| Breast cancer pathway 0.3211833031958285 0.1359153192835419 0.8918882248215845 1.0 1.0 25 P28482,P49841,P67870,Q04721,Q02750,P08069 6 |
| Leptin signaling pathway 0.3199343514251618 0.13112568566847 0.8956758823635109 1.0 1.0 26 P62753,P49841,P54646,O75116,P28482,Q02750,P49840 7 |
| Bdnftrkb signaling 0.3157554827500622 0.1306299616330278 0.8960680398563934 1.0 1.0 8 Q02750,P28482 2 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.2920417251402294 0.1130949203605072 0.9099553021209544 1.0 1.0 39 P62753,P54646,P49841,P28482,P08238,P30153,Q14738,Q02750,P07900,P14625 10 |
| Nucleotide excision repair 0.3150978910666024 0.1111060160233613 0.9115322781852708 1.0 1.0 27 P15927,P54727,Q9NRF9 3 |
| Nrf2are regulation 0.3029933727209581 0.1066613440070482 0.9150576506175668 1.0 1.0 9 Q96HS1,P48507,P49841 3 |
| Neural crest cell migration during development 0.3290831815421975 0.1027258280797139 0.918180574239254 1.0 1.0 5 Q99570,P63000,P40763,Q13177 4 |
| Tca cycle in senescence 0.3021417759056678 0.0932499140031109 0.9257050214626784 1.0 1.0 8 P08559 1 |
| Tcell activation sarscov2 0.2889867948763974 0.0880092136971503 0.9298693530897107 1.0 1.0 12 P49841,P28482 2 |
| Tryptophan metabolism 0.2931473772799779 0.082387908467747 0.9343382510059284 1.0 1.0 14 P40939 1 |
| Dna damage response only atm dependent 0.300047628134594 0.0690303103749973 0.9449654928478586 1.0 1.0 19 P09429 1 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.3093122012055577 0.0685612799726704 0.9453388404136632 1.0 1.0 5 P48507,Q13155 2 |
| Nrf2 pathway 0.3035545677947996 0.0682145521323125 0.945614843028387 1.0 1.0 22 P48507,Q99735,P30043,P30041,P07900,P08238,P52209 7 |
| Met in type 1 papillary renal cell carcinoma 0.2991169925464597 0.0656945710148633 0.9476209947803388 1.0 1.0 19 P63000,Q92733,P28482,P19174,Q02750 5 |
| Electron transport chain oxphos system in mitochondria 0.2594668662745608 0.0655920695362183 0.9477026031110208 1.0 1.0 45 P15954,P20674,P09669,P24539,Q9UDW1,P13073 6 |
| Familial partial lipodystrophy fpld 0.283898136452576 0.0499403685358857 0.9601699079819984 1.0 1.0 7 O75844,O60725,P02545 3 |
| Development of ureteric collection system 0.2891571785003332 0.040784627305395 0.9674675947951272 1.0 1.0 5 P35222,Q13418 2 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.2731383624270304 0.0369373205044907 0.970534982580598 1.0 1.0 12 Q7Z434,Q6PKG0,P35613 3 |
| Id signaling pathway 0.4646648468304563 0.0282360144284352 0.9774739133069928 1.0 1.0 2 P24941 1 |
| Mammary gland development pathway involution stage 4 of 4 0.4440400363967267 0.0230065221438519 0.981645070408826 1.0 1.0 2 P04637 1 |
| Wnt signaling pathway 0.268178173525896 0.0225424173818286 0.9820152764086962 1.0 1.0 12 P49840,P28482,P49841 3 |
| Tp53 network 0.4322111010009106 0.0207375002009636 0.9834550546106836 1.0 1.0 2 P04637 1 |
| Progeriaassociated lipodystrophy 0.268731129667014 0.0194660429747763 0.9844693256882232 1.0 1.0 9 O75844,P46063,P02545,O60725 4 |
| Gaba metabolism aka ghb 0.4231119199272054 0.0192962582784564 0.9846047688353388 1.0 1.0 2 O43488 1 |
| Epithelial to mesenchymal transition in colorectal cancer 0.2827540234952258 0.0176745271198351 0.9858985018873492 1.0 1.0 18 P28482,Q04721,P49841,Q9Y3F4,Q02750 5 |
| Male infertility 0.2900097100143138 0.0171707233612599 0.9863004181187034 1.0 1.0 23 Q9Y617,P17096,Q15165,P08183 4 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.2671257160254192 0.0161210949066136 0.987137784399416 1.0 1.0 9 Q8WUM4,P28482 2 |
| Robo4 and vegf signaling pathways crosstalk 0.3306035790112173 0.0135235548952135 0.9892100932310556 1.0 1.0 2 P63000 1 |
| Genes controlling nephrogenesis 0.26316924534248 0.0102448805349241 0.9918259109829276 1.0 1.0 8 Q04721,P35222,Q13418,P05556 4 |
| Neuroinflammation and glutamatergic signaling 0.2828860520544163 0.0021335701443654 0.9982976586139652 1.0 1.0 21 P08559,Q9Y617,P28482 3 |
| Atm signaling in development and disease 0.2851395059476036 0.001503964429827 0.9988000104538222 1.0 1.0 23 O43683,Q5VTR2 2 |
|
|
